文献速递神经肿瘤

成人胶质瘤患者多模式治疗后的长期神经认知功能与生活质量:一项前瞻性长期随访研究

Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up.
PubMed 文献 · J Neurooncol · 2023-08-30

这项前瞻性多中心研究对71例WHO 1-4级胶质瘤患者进行基线与中位7.1年后的神经认知测试和生活质量问卷,并在27例放疗患者中分析同侧海马平均放疗剂量与认知的关联。结果显示除单纯化疗组的选择性注意力外,各治疗模式各认知域平均表现均无显著下降;海马Dmean>50 Gy与<10 Gy相比,除抑制子测试外与长期认知功能无关联。

要点

  • 多模式胶质瘤治疗对神经认知的影响似乎小于通常假设。
  • 除单纯化疗组选择性注意力外,各治疗模式各认知域平均表现无显著下降。
  • 海马Dmean>50 Gy与<10 Gy相比,除抑制子测试外与长期认知功能无关联。

核心结论

  • 多模式胶质瘤治疗对神经认知的影响似乎小于通常假设。
  • 即使单侧海马受照>50 Gy,本系列患者也未出现严重认知下降。

研究设计与样本

  • 前瞻性多中心研究,纳入71例WHO 1-4级胶质瘤患者,串联进行神经认知测试和生活质量问卷。
  • 在基线与进一步治疗后(基线后中位7.1年,范围4.6-11.0年)应用标准化计算机神经认知测试组合(NeuroCog FX)。
  • 在27例接受放疗的患者亚组中,根据放疗计划确定同侧海马平均放疗剂量,以评估其与神经认知的关联。

主要发现

  • 基线与随访之间,任何治疗模式(放疗、化疗、放化疗联合、观察等待)下各认知域平均表现均无显著下降,但单纯化疗组的选择性注意力除外。
  • 同侧海马Dmean>50 Gy与<10 Gy相比,除抑制子测试外,与长期认知功能无关联。
  • Dmean<10 Gy的患者在所有认知域表现稳定或改善,而>50 Gy的患者在4/8个认知域出现数值上的下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Multimodal therapies have significantly improved prognosis in glioma. However, in particular radiotherapy may induce long-term neurotoxicity compromising patients' neurocognition and quality of life. The present prospective multicenter study aimed to evaluate associations of multimodal treatment with neurocognition with a particular focus on hippocampal irradiation. METHODS: Seventy-one glioma patients (WHO grade 1-4) were serially evaluated with neurocognitive testing and quality of life questionnaires. Prior to (baseline) and following further treatment (median 7.1 years [range 4.6-11.0] after baseline) a standardized computerized neurocognitive test battery (NeuroCog FX) was applied to gauge psychomotor speed and inhibition, verbal short-term memory, working memory, verbal and non-verbal memory as well as verbal fluency. Mean ipsilateral hippocampal radiation dose was determined in a subgroup of 27 patients who received radiotherapy according to radiotherapy plans to evaluate its association with neurocognition. RESULTS: Between baseline and follow-up mean performance in none of the cognitive domains significantly declined in any treatment modality (radiotherapy, chemotherapy, combined radio-chemotherapy, watchful-waiting), except for selective attention in patients receiving chemotherapy alone. Apart from one subtest (inhibition), mean ipsilateral hippocampal radiation dose > 50 Gy (Dmean) as compared to < 10 Gy showed no associations with long-term cognitive functioning. However, patients with Dmean < 10 Gy showed stable or improved performance in all cognitive domains, while patients with > 50 Gy numerically deteriorated in 4/8 domains. CONCLUSIONS: Multimodal glioma therapy seems to affect neurocognition less than generally assumed. Even patients with unilateral hippocampal irradiation with > 50 Gy showed no profound cognitive decline in this series.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Pertz M, Schlömer S, Seidel C, et al. Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up. J Neurooncol. 2023. PMID: 37648934. doi:10.1007/s11060-023-04419-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。